XML 54 R37.htm IDEA: XBRL DOCUMENT v3.25.1
Collaboration and License Agreements - Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Disaggregation of Revenue [Line Items]        
Revenue $ 542,709 $ 0 $ 545,209 $ 3,551
GSK        
Disaggregation of Revenue [Line Items]        
Revenue 3 0 2,503 2,685
Takeda        
Disaggregation of Revenue [Line Items]        
Revenue 0 0 0 866
Sarepta        
Disaggregation of Revenue [Line Items]        
Revenue $ 542,706 $ 0 $ 542,706 $ 0